Cameron Herberts

机构：University of British Columbia, Texas Oncology, Natera (United States), The Prostate Centre

发表论文 276 篇 · 总被引 1418 次 · h-index 16

代表论文

• Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial (2026 · Nature Medicine · 被引 8)
• Circulating tumor DNA (ctDNA) to guide response-adapted bladder preservation in muscle invasive bladder cancer (MIBC): Integrated analysis of the RETAIN trials. (2026 · Journal of Clinical Oncology · 被引 7)
• Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer (2026 · Clinical Cancer Research · 被引 5)
• ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer (2026 · Clinical Cancer Research · 被引 5)
• Data from Clonal Hematopoiesis after <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Prostate Cancer (2026 · 被引 1)
• Supplementary Tables S1 - S6 from Clonal Hematopoiesis after <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Prostate Cancer (2026)